Med-tech company HealthBeacon announce €5m funding round
Dublin based med-tech company HealthBeacon is embarking on a new €5m round of investment funding.
The company, which connects real life data about a patient’s behaviour and can provide powerful clinical insights and targeted interventions to improve treatment and outcomes, aims to raise the funds before the end of 2018.
"We are excited to announce HealthBeacon’s next investment phase as we continue to move towards global connection of healthcare through assisting in clever patient medication management and revolutionizing medication adherence.
Our technology provides powerful insights for medics by providing real world patient data," Jim Joyce, CEO, HealthBeacon, said.
To-date HealthBeacon has raised over €3m with current investors including Elkstone Partners and Oyster Capital.
The funding announcement was made at an "Investing in Digital Health" event, a private investor event hosted by HealthBeacon.
The event gathered authorities from the world of medical tech, medical entrepreneurs, and investors for the purpose of discussing growth and investment opportunities in digital health.
Earlier this year HealthBeacon announced the creation of 20 new jobs in Dublin, bringing its total headcount to 37.
The company’s "Smart Sharps System" helps patients adhere to their medication schedule and, the expansion of the platform will provide access to the technology globally in Europe, North America, South America and the Middle East.